n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Lung Diseases, Interstitial in 1 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyakawa, H | 1 |
| Mason, RP | 1 |
| Jiang, J | 1 |
| Kadiiska, MB | 1 |
1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Lipid-derived free radical production in superantigen-induced interstitial pneumonia.
Topics: Allopurinol; Amidines; Animals; Anti-Inflammatory Agents; Benzylamines; Cell Movement; Deferoxamine; | 2009 |